Effect of thrombus composition on first pass recanalization and bleeding in acute ischemic stroke patients
Published in General & Internal Medicine
Specifically, it investigates whether clots rich in red blood cells (RBCs) or those dominated by platelets and fibrin influence the likelihood of achieving first-pass recanalization (FPR)—a successful reopening of the blocked artery in a single attempt—and the risk of bleeding complications. While clot composition was not significantly linked to FPR success, it was strongly associated with the risk of intracranial hemorrhage. These findings suggest that clot histology could play a key role in predicting post-treatment complications, highlighting its potential clinical value beyond the known importance of achieving FPR.
Follow the Topic
-
Journal of Thrombosis and Thrombolysis
This journal is a resource for those involved in the treatment and clinical investigation of thrombotic disorders involving the cardiovascular and cerebrovascular systems.
Related Collections
With Collections, you can get published faster and increase your visibility.
Thrombosis and bleeding in structural heart disease – current evidence and clinical challenges
This collection aims to bring together cutting edge-reviews and clinical perspectives on thrombosis and bleeding in structural heart disease. Manuscript are welcome that address pathophysiology of device- and procedure related thrombotic risk (e.g. in TAVR, mitral and tricuspid interventions, LAA and PFO occlusion, VADs). Moreover, the collection will consider papers about clinical and procedural risk assessment including novel imaging techniques and biomarker analysis and will also cover gender and ethnic differences of thrombotic and bleeding risk after structural heart interventions.
Publishing Model: Hybrid
Deadline: Jul 31, 2026
Heart, Brain, and Clot: Emerging Perspectives on Thrombosis
This focus issue aims to highlight emerging concepts at the intersection of cardiovascular disease, cerebrovascular disease, and thrombosis, with particular emphasis on the biological, clinical, and translational mechanisms linking the heart, brain, and vascular system. Increasing recognition of the interconnected nature of cardiac, cerebrovascular, and systemic vascular disease has reshaped our understanding of thrombosis beyond isolated organ systems, with thrombotic mechanisms increasingly implicated in acute vascular events, recurrent embolism, vascular ageing, and cognitive dysfunction. These developments have created new opportunities for multidisciplinary research spanning basic science, imaging, biomarkers, clinical trials, and translational medicine.
We welcome review articles, meta-analyses, original research (clinical, translational, or basic science), or expert consensus statements addressing topics including, but not limited to, cardioembolic stroke and embolic stroke of undetermined source (ESUS); atrial cardiopathy, atrial fibrillation detected after stroke (AFDAS), and cardiac sources of embolism; heart–brain interactions across cardiovascular and cerebrovascular disease; cardiovascular disease and cognitive impairment; multimodal imaging and biomarkers across the heart-brain axis; antithrombotic therapies and secondary prevention; vascular biology and inflammation; and precision medicine, AI, and emerging approaches to heart–brain research.
Publishing Model: Hybrid
Deadline: Oct 01, 2026
